DNA GTx’s BRCA 1 / 2 Panel focuses on two of the most well-established genes linked to hereditary breast, ovarian, and prostate cancer syndromes. By analyzing germline variants in BRCA1 and BRCA2, this test helps identify individuals at increased genetic risk—enabling proactive screening, risk-reducing strategies, and personalized care planning.
Yes. A healthcare provider must order the test and will help you understand the results and what they mean for your health care.
Let’s Decode the Future of Health — Together
Get in touch today — let’s start a conversation that could change lives
*All information is handled with strict confidentiality.
Find Answers Today
Early detection saves lives
*All information is handled with strict confidentiality.